All Stories

  1. Abulia major and hypoactive delirium in COVID-19 reversed with methylprednisolone pulse therapy
  2. Abulia major and hypoactive delirium in COVID-19 reversed with methylprednisolone pulse therapy
  3. Abulia major and hypoactive delirium in COVID-19 reversed with methylprednisolone pulse therapy
  4. Methylprednisolone treats neuropsychiatric phenomena in COVID-19
  5. The COVID-19 "Bad Tryp" Syndrome: NAD/NADH+, Tryptophan Phenylalanine Metabolism and Thermogenesis like Hecatomb - The Hypothesis of Pathophysiology Based on a Compared COVID-19 and Yellow Fever Inflammatory Skeleton
  6. Out of Sight, Out of Mind, Right? Not in COVID-19 Shock or Anaerobic and Exhaustive Shock <i>versus</i> Septic Shock Dilemma That Means to Live or Die. Emergency Attention and a Necessity of Trials
  7. NEUROCOV/PSYCCOV: Neuropsychiatric Phenomena in COVID-19 - Exposing Their Hidden Essence and Warning against Iatrogenesis
  8. The COVID-19 Burden or Tryptophan Syndrome: Autoimmunity, Immunoparalysis and Tolerance in a Tumorigenic Environment
  9. Methylprednisolone Pulse Therapy in COVID-19 as the First Choice for Public Health: When Right Timing Breaks Controversies—Emergency Guide
  10. Consumptive coagulopathy of severe yellow fever occurs independently of hepatocellular tropism and massive hepatic injury
  11. Clinical and epidemiological profile of patients in the chronic phase of Chagas disease treated at a reference center in the Southeast region of Brazil
  12. Predictors of mortality in patients with yellow fever: an observational cohort study
  13. Rupioid lesions, PLEVA and superposition phenomenon in malignant syphilis: two case reports in HIV-infected patients
  14. Erythema multiforme by syphilis
  15. Cholinergic reflex in Chagas disease